| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A portion of amino acids 500-800 from human FLT3 protein was used as the immunogen for the Fms-like tyrosine kinase 3 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Fms-like tyrosine kinase 3 Antibody / FLT3 / CD135 is an antibody targeting Fms-like. Host: Mouse. Monoclonal. Clone: FLT3/9887. Format: Purified. Applications: IHC-P.
Key elements and design rationale
- Target: Fms-like.
- Immunogen: A portion of amino acids 500-800 from human FLT3 protein was used as the immunogen for the Fms-like tyrosine kinase 3 a….
- Species reactivity: Human.
- Localization: Cytoplasm, Membrane.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
Tyrosine-protein kinase that acts as a cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. [UniProt]
Common research applications
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
